Antimicrobial activity of the medicinal product Amclav®Vet against field strains of microorganisms recovered from cats and dogs

<jats:p>Study evaluated antimicrobial activity of combined antibacterial veterinary drug Amclav®Vet (amoxicillin/clavulanic acid) against 140 wild strains isolated from cats and dogs with various bacterial diseases. Sensitivity of pathogenic strains, most commonly isolated from cats and dogs with dermatological problems, upper respiratory tract diseases, and urinary system diseases was evaluated. During the study high antimicrobial activity against S. pseudintermedius (94.8%) and P. multocida (100%), and of E. coli (72.5%) was detected. The results of the study confirm the effectiveness of Amclav®Vet in the treatment of bacterial infections caused by strains, sensitive to the combined antibiotic, in small animals</jats:p>